Previous Article | Next Article ![]()
Infection and Immunity, June 1999, p. 2996-3001, Vol. 67, No. 6
Department of Clinical Investigation, Texas
Center for Infectious Disease, San Antonio, Texas 78223
Received 6 January 1999/Returned for modification 20 February
1999/Accepted 24 March 1999
T-cell-mediated immunity is an important determinant in protection
against primary infection with Coccidioides immitis, a dimorphic fungal pathogen that causes the disease coccidioidomycosis. To determine if interleukin-12 (IL-12) gene therapy could potentiate host response against C. immitis, we constructed a
single-chain cDNA encoding the p40 and p35 subunits linked by a
polylinker and, using a retroviral vector, transfected J774 macrophages
with the construct. The transduced J774 cells expressed IL-12 in vitro, with a mean concentration of 28,440 pg from 106 cells in 48 h as measured by an IL-12 (p75)-specific enzyme-linked immunosorbent
assay. The secreted IL-12 was biologically active, as judged by its
ability to induce the production of gamma interferon (IFN-
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Construction of a Single-Chain
Interleukin-12-Expressing Retroviral Vector and Its Application in
Cytokine Gene Therapy against Experimental Coccidioidomycosis
) by
spleen cells from BALB/c mice. Treatment of the highly susceptible
BALB/c mouse strain with the IL-12-transduced J774 cells inhibited
C. immitis growth in tissues from mice challenged by a
pulmonary route, as evidenced by 1.37-, 2.59-, and 1.22-log reductions
in the number of CFU in the lungs, spleens, and livers, respectively,
compared to the fungal load in mice given vector-transduced J774 cells.
The protective effect of IL-12 gene therapy was accompanied by
increased levels of IFN-
in the lungs and sera of mice treated with
IL-12-transduced J774 cells and the constitutive production of IFN-
by their spleen cells cultured in vitro. These results suggest that
IL-12 gene therapy could be used as adjunct therapy for coccidioidomycosis.
*
Corresponding author. Mailing address: Dept. of
Clinical Investigation, Texas Center for Infectious Disease, 2303 SE
Military Dr., San Antonio, TX 78223. Phone: (210) 534-8857. Fax: (210) 531-4550. E-mail: chengyong.jiang{at}tdh.state.tx.us.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»